Group One Trading, L.P. Kodiak Sciences Inc. Transaction History

Group One Trading, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$4.3 - $9.48 $158,760 - $350,011	36,921 New	36,921 $254,000
Q3 2022 Nov 09, 2022	BUY	$7.57 - $12.5 $19,152 - $31,625	2,530 Added 85.82%	5,478 $42,000
Q2 2022 Aug 11, 2022	SELL	$5.04 - $9.48 $16,873 - $31,739	-3,348 Reduced 53.18%	2,948 $23,000
Q1 2022 May 12, 2022	BUY	$7.09 - $89.45 $19,596 - $247,239	2,764 Added 78.26%	6,296 $49,000
Q4 2021 Feb 11, 2022	SELL	$80.85 - $128.49 $412,335 - $655,299	-5,100 Reduced 59.08%	3,532 $299,000
Q3 2021 Nov 12, 2021	BUY	$81.97 - $106.94 $49,182 - $64,164	600 Added 7.47%	8,632 $829,000
Q2 2021 Aug 10, 2021	BUY	$77.2 - $126.54 $162,120 - $265,734	2,100 Added 35.4%	8,032 $747,000
Q1 2021 May 12, 2021	BUY	$110.45 - $164.47 $655,189 - $975,636	5,932 New	5,932 $673,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $455M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.